How recent of a development is this? That is some very good news - for shareholders and those that are interested in having possible tissue repair done. Was that a last round of dilution this week then, or pure games being played by those with enough shares/capital to manipulate the price in whatever direction they decided? A headline stating that enough money has been raised for the initiation of FDA testing/trials would do wonders, considering the initially appraised value of the patent and current market cap. Also, why is the number listed on OTC have a CC for great britain, when they are incorporated in Wyoming and supposed to be based out of Florida? Some oddities in the mix on that one. I will contact them soon, just want to try and avoid asking the same questions over and over.